Drug
Recombinant Human Erythropoietin
Recombinant Human Erythropoietin: highest development phase Phase 3, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| recombinant human erythropoietin NCT00144495 | Phase 3 | Chemotherapy Induced Anemia |
Latest
No recent events.
Follow Recombinant Human Erythropoietin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.